Study of ZG006 in Participants With Neuroendocrine Prostate Cancer

NCT07024277 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroendocrine Prostate Cancer

Interventions

BIOLOGICAL: ZG006

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd